Library Subscription: Guest
Critical Reviews™ in Oncogenesis

Published 4 issues per year

ISSN Print: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Functional Foods in the Prevention of Colorectal Cancer

Volume 25, Issue 2, 2020, pp. 111-128
DOI: 10.1615/CritRevOncog.2020035112
Get accessGet access

ABSTRACT

Colorectal cancer (CRC) ranks second for incidence in females (third in males). Currently, a broad spectrum of treatment options exists for the treatment of colorectal tumors. However, existing therapeutic options often lead to trauma, side effects, and high cost. Hence, there is an ongoing quest to detect novel approaches for the treatment of colon cancer. Recently, multiple studies have reported that consuming functional foods that are loaded with natural compounds can prevent the risk of CRC. In this review, the authors have attempted to collect information about the best possible foods and their active ingredients that may be used in treatment. Information retrieved through research reveals that all functional foods have aroma, taste, and nutritive value along with active ingredients that are beneficial for human health. For instance, the consumption of red meat increases CRC risk; on the other hand, the consumption of fresh vegetables diminishes such risk. Additionally, plant-based diets comprise fibers, bioactive compounds, and micronutrients, which are reported to have antioxidant as well as anticancer properties. Bioactively rich functional foods have been reported to provide protection against CRC. However, few active components like curcumin work in a dose-dependent manner. Thus, the involvement of medical practitioners during a clinical trial is highly recommended. In general, these active dietary components may aid in improving the health and well-being of patients as well as in managing the risk associated with cancer in a more comprehensive way.

REFERENCES
  1. Koveitypour Z, Panahi F, Vakilian M, Peymani M, Forootan FS, Esfahani MH, Ghaedi K. Signaling pathways involved in colorectal cancer progression. Cell Biosci. 2019 Dec 1;9(1):97. doi: 10.1186/s13578-019-0361-4.

  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clinicians. 2018 Nov;68(6):394-424.

  3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: Cancer J Clinicians. 2019 Jan;69(1):7-34.

  4. Keum N, Giovannucci E. Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019 Dec;16(12):713-32.

  5. van der Stok EP, Spaander MC, Grunhagen DJ, Verhoef C, Kuipers EJ. Surveillance after curative treatment for colorectal cancer. Nat Rev Clin Oncol. 2017 May;14(5):297-315.

  6. Feng W, Ao H, Peng C. Gut microbiota, short-chain fatty acids, and herbal medicines. Front Pharmacol. 2018 Nov 23;9:1354. doi: 10.3389/fphar.2018.01354.

  7. Koch S. Extrinsic control of Wnt signaling in the intestine. Differentiation. 2017 Sep 1;97:1-8.

  8. Bond CE, McKeone DM, Kalimutho M, Bettington ML, Pearson SA, Dumenil TD, Wockner LF, Burge M, Leggett BA, Whitehall VL. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis. Oncotarget. 2016 Oct 25;7(43):70589-600.

  9. Schatoff EM, Leach BI, Dow LE. Wnt signaling and colorectal cancer. Curr Colorectal Cancer Rep. 2017 Apr 1;13(2):101-10.

  10. Tiwari A, Saraf S, Verma A, Panda PK, Jain SK. Novel targeting approaches and signaling pathways of colorectal cancer: An insight. World J Gastroenterol. 2018 Oct 21;24(39):4428-35.

  11. Liao W, Li G, You Y, Wan H, Wu Q, Wang C, Lv N. Antitumor activity of Notch1 inhibition in human colorectal carcinoma cells. Oncol Rep. 2018 Mar 1;39(3):1063-71.

  12. Lian H, Jia X, Shi N, Xie S, Wang J, Wang W, Ma F, Liu H, Wang A, Cheng X, Liu C. Notch signaling promotes serrated neoplasia pathway in colorectal cancer through epigenetic modification of EPHB2 and EPHB4. Cancer Manage Res. 2018 Nov 22;6129-41.

  13. Du Y, Li D, Li N, Su C, Yang C, Lin C, Chen M, Wu R, Li X, Hu G. POFUT1 promotes colorectal cancer development through the activation of Notch1 signaling. Cell Death Dis. 2018 Sep 24;9(10):1-2.

  14. Dandawate P, Subramaniam D, Panovich P, Standing D, Krishnamachary B, Kaushik G, Thomas SM, Dhar A, Weir SJ, Jensen RA, Anant S. Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway. Sci Rep. 2020 Jan 28;10(1):1-5.

  15. Wang Z, Jin H, Xu R, Mei Q, Fan D. Triptolide down-regulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression. Exper Mol Med. 2009 0ct;41(10):717-27.

  16. Farooqi AA, De La Roche M, Djamgoz MB, Siddik ZH. Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights. Sem Cancer Biol. 2019 Oct 1;58:65-79.

  17. Park SY, Lee CJ, Choi JH, Kim JH, Kim JW, Kim JY, Nam JS. The JAK2/STAT3/CCND2 axis promotes colorectal cancer stem cell persistence and radioresistance. J Exper Clin Cancer Res. 2019 Dec;38(1):1-8.

  18. Narayanankutty A. PI3K/Akt/mTOR pathway as a therapeutic target for colorectal cancer: A review of preclinical and clinical evidence. Curr Drug Target. 2019 Sep 1;20(12):1217-26.

  19. Itatani Y, Kawada K, Sakai Y. Transforming growth factor-P signaling pathway in colorectal cancer and its tumor microenvironment. Int J Mol Sci. 2019 Jan;20(23):5822.

  20. Yang D, Hou T, Li L, Chu Y, Zhou F, Xu Y, Hou X, Song H, Zhu K, Hou Z, Peng H. Smad1 promotes colorectal cancer cell migration through Ajuba transactivation. Oncotarget. 2017 Dec 15;8(66):110415-25.

  21. Gu C, Wang X, Long T, Wang X, Zhong Y, Ma Y, Hu Z, Li Z. FSTL1 interacts with VIM and promotes colorectal cancer metastasis via activating the focal adhesion signaling pathway. Cell Death Dis. 2018 May 29;9(6):1-4.

  22. Cai J, Xia L, Li J, Ni S, Song H, Wu X. Tumor-associated macrophages derived TGF-P-induced epithelial to mesenchymal transition in colorectal cancer cells through smad2, 3-4/snail signaling pathway. Cancer Res Treat. 2019 Jan;51(1):252-66.

  23. Slattery ML, Curtin K, Wolff RK, Boucher KM, Sweeney C, Edwards S, Caan BJ, Samowitz W. A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum. 2009 Jul;52(7):1304-11.

  24. Kowalczyk AE, Krazinski BE, Godlewski J, Kiewisz J, Kwiatkowski P, Sliwinska-Jewsiewicka A, Kiezun J, Sulik M, Kmiec Z. Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival. Oncology Rep. 2017 Jul 1;38(1):201-10.

  25. Huang Y, Liu N, Liu J, Liu Y, Zhang C, Long S, Luo G, Zhang L, Zhang Y. Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA. Cell Cycle. 2019 Dec 17;18(24):3442-55.

  26. Aiello P, Sharghi M, Mansourkhani SM, Ardekan AP, Jouybari L, Daraei N, Peiro K, Mohamadian S, Rezaei M, Heidari M, Peluso I. Medicinal plants in the prevention and treatment of colon cancer. Oxidative Med Cell Longevity. 2019 Dec 4;2019. doi: 10.1155/2019/2075614.

  27. Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transd Target Ther. 2020 Mar 20;5(1):1-30.

  28. Huang XM, Yang ZJ, Xie Q, Zhang ZK, Zhang H, Ma JY. Natural products for treating colorectal cancer: A mechanistic review. Biomed Pharmacother. 2019 Sep 1;117:109142. doi: 10.1016/j.biopha.2019.109142.

  29. DiMarco-Crook C, Xiao H. Diet-based strategies for cancer chemoprevention: The role of combination regimens using dietary bioactive components. Annu Rev Food Sci Technol. 2015 Apr 10;6:505-26.

  30. Gupta MK, Vadde R. Genetic basis of adaptation and maladaptation via balancing selection. Zoology. 2019 Oct 1;136:125693. doi: 10.1016/j.zool.2019.125693.

  31. Mallepalli S, Gupta MK, Vadde R. Neuroblastoma: An updated review on biology and treatment. Curr Drug Metab. 2019 Nov 1;20(13):1014-22.

  32. Hasler CM. Functional foods: Benefits, concerns and challenges-a position paper from the American Council on Science and Health. J Nutr. 2002 Dec 1;132(12):3772-81.

  33. Lanou AJ, Svenson B. Reduced cancer risk in vegetarians: An analysis of recent reports. Cancer Manage Res. 2011;3:1-8.

  34. Gupta MK, Sarojamma V, Reddy MR, Shaik JB, Vadde R. Computational biology: Toward early detection of pancreatic cancer. Crit Rev Oncogenesis. 2019;24(2):191-8.

  35. Gupta MK, Vadde R, Sarojamma V. Curcumin-A novel therapeutic agent in the prevention of colorectal cancer. Curr Drug Metab. 2019 Oct 1;20(12):977-87.

  36. Afrin S, Giampieri F, Gasparrini M, Forbes-Hernandez TY, Cianciosi D, Reboredo-Rodriguez P, Zhang J, Manna PP, Daglia M, Atanasov AG, Battino M. Dietary phytochemicals in colorectal cancer prevention and treat-ment: A focus on the molecular mechanisms involved. Biotechnol Adv. 2020 Jan 1;38:107322. doi: 10.1016/j. biotechadv. 2018.11.011.

  37. El-Bayoumy K, Sinha R, Pinto JT, Rivlin RS. Cancer chemoprevention by garlic and garlic-containing sulfur and selenium compounds. J Nutr. 2006 Mar 1;136(3):864S-69S.

  38. Ngo SN, Williams DB, Cobiac L, Head RJ. Does garlic reduce risk of colorectal cancer? A systematic review. J Nutr. 2007 0ct;137(10):2264-69.

  39. Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-KB signaling. Int J Cancer. 2004 Sep 20;111(5):679-92.

  40. Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-KB and IKB proteins: Implications in cancer and inflammation. Trends Biochem Sci. 2005 Jan 1;30(1):43-52.

  41. Karin M. NF-KB as a critical link between inflammation and cancer. Cold Spring Harbor Perspect Biol. 2009 Nov 1;1(5):a000141. doi: 10.1101/cshperspect.a000141.

  42. Yanaka A, Suzuki H, Mutoh M, Kamoshida T, Kakinoki N, Yoshida S, Hirose M, Ebihara T, Hyodo I. Chemopre-vention against colon cancer by dietary intake of sulforaphane. Funct Food Health Dis. 2019 Jul 1;9(6):392-411.

  43. Hsiao YC, Kuo WH, Chen PN, Chang HR, Lin TH, Yang WE, Hsieh YS, Chu SC. Flavanone and 2'-OH flavanone inhibit metastasis of lung cancer cells via down-regulation of proteinases activities and MAPK pathway. Chem-Biol Interact. 2007 May 1;167(3):193-206.

  44. Nagaprashantha LD, Vatsyayan R, Singhal J, Lelsani P, Prokai L, Awasthi S, Singhal SS. 2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma. Carcinogenesis. 2011 Apr 1;32(4):568-75.

  45. Gervazoni LF, Gonjalves-Ozorio G, Almeida-Amaral EE. 2'-Hydroxyflavanone activity in vitro and in vivo against wild-type and antimony-resistant Leishmania amazonensis. PLoS NTDs. 2018 Dec 6;12(12):e0006930. doi: 10.1371/journal.pntd.0006930.

  46. La X, Zhang L, Li Z, Li H, Yang Y. (-)-Epigallocatechin Gallate (EGCG) enhances the sensitivity of colorectal cancer cells to 5-FU by inhibiting GRP78/NF-KB/miR-155-5p/MDR1 pathway. J Agric Food Chem. 2019 Feb 11;67(9):2510-18.

  47. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin Chim Acta. 1995 Mar 31;235(2):207-19.

  48. Shankar S, Singh G, Srivastava RK. Chemoprevention by resveratrol: Molecular mechanisms and therapeutic potential. Front Biosci. 2007 Sep 1;12:4839-54.

  49. Saiprasad G, Chitra P, Manikandan R, Sudhandiran G. Hesperidin induces apoptosis and triggers autophagic markers through inhibition of Aurora-A mediated phosphoinositide-3-kinase/Akt/mammalian target of rapamycin and glycogen synthase kinase-3 beta signalling cascades in experimental colon carcinogenesis. Eur J Cancer. 2014 Sep 1;50(14):2489-507.

  50. Vanamala J, Leonardi T, Patil BS, Taddeo SS, Murphy ME, Pike LM, Chapkin RS, Lupton JR, Turner ND. Suppression of colon carcinogenesis by bioactive compounds in grapefruit. Carcinogenesis. 2006 Jun 1;27(6):1257-65.

  51. Leonardi T, Vanamala J, Taddeo SS, Davidson LA, Murphy ME, Patil BS, Wang N, Carroll RJ, Chapkin RS, Lupton JR, Turner ND. Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats. Exper Biol Med. 2010 Jun;235(6):710-7.

  52. Vadde R, Radhakrishnan S, Reddivari L, Vanamala JK. Triphala extract suppresses proliferation and induces apoptosis in human colon cancer stem cells via suppressing c-Myc/Cyclin D1 and elevation of Bax/ Bcl-2 ratio. BioMed Res Int. 2015 Jun 17;2015. doi: 10.1155/2015/649263.

  53. Massey AR, Reddivari L, Radhakrishnan S, Charepalli V, Hewage EK, Ramakrishna V, Vanamala JK. Pro-apoptotic activity against cancer stem cells differs between different parts of sweet sorghum. J Funct Food. 2016 May 1;23:601-13.

  54. Seeram NP, Adams LS, Hardy ML, Heber D. Total cranberry extract versus its phytochemical constituents: Anti-proliferative and synergistic effects against human tumor cell lines. J Agric Food Chem. 2004 May 5;52(9):2512-7.

  55. Howell AB, Reed JD, Krueger CG, Winterbottom R, Cunningham DG, Leahy M. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry. 2005 Sep 1;66(18):2281-91.

  56. Charepalli V, Reddivari L, Vadde R, Walia S, Radhakrishnan S, Vanamala JK. Eugenia jambolana (Java plum) fruit extract exhibits anticancer activity against early stage human HCT-116 colon cancer cells and colon cancer stem cells. Cancer. 2016 Mar;8(3):29. doi: 10.3390/ cancers8030029.

  57. Cvorovic J, Tramer F, Granzotto M, Candussio L, Decorti G, Passamonti S. Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells. Arch Biochem Biophys. 2010 Sep 1;501(1):151-57.

  58. Kee JY, Han YH, Kim DS, Mun JG, Park J, Jeong MY, Um JY, Hong SH. Inhibitory effect of quercetin on colorectal lung metastasis through inducing apoptosis, and suppression of metastatic ability. Phytomedicine. 2016 Dec 1;23(13):1680-90.

  59. Yang L, Liu Y, Wang M, Qian Y, Dong X, Gu H, Wang H, Guo S, Hisamitsu T. Quercetin-induced apoptosis of HT-29 colon cancer cells via inhibition of the Akt-CSN6-Myc signaling axis. Mol Med Rep. 2016 Nov 1;14(5):4559-66.

  60. Vadde R, Radhakrishnan S, Kurundu HE, Reddivari L, Vanamala JK. Indian gooseberry (Emblica officinalis Gaertn.) suppresses cell proliferation and induces apoptosis in human colon cancer stem cells independent of p53 status via suppression of c-Myc and cyclin D1. J Funct Food. 2016 Aug 1;25:267-78.

  61. Charepalli V, Reddivari L, Radhakrishnan S, Vadde R, Agarwal R, Vanamala JK. Anthocyanin-containing purple-fleshed potatoes suppress colon tumorigenesis via elimination of colon cancer stem cells. J Nutr Biochem. 2015 Dec 1;26(12):1641-49.

  62. Rosillo MA, Sanchez-Hidalgo M, Cardeno A, Aparicio-Soto M, Sanchez-Fidalgo S, Villegas I, de la Lastra CA. Dietary supplementation of an ellagic acid-enriched pomegranate extract attenuates chronic colonic inflammation in rats. Pharmacol Res. 2012 Sep 1;66(3):235-42.

  63. Belli V, Sforza V, Cardone C, Martinelli E, Barra G, Matrone N, Napolitano S, Morgillo F, Tuccillo C, Federico A, Dallio M. Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic col-orectal cancer. Oncotarget. 2017 Sep 15;8(40):68305-16.

  64. Wang Y, Lu P, Zhang W, Du Q, Tang J, Wang H, Lu J, Hu R. GEN-27, a newly synthetic isoflavonoid, inhibits the proliferation of colon cancer cells in inflammation microenvironment by suppressing NF-KB pathway. Mediators Inflamm. 2016 Jan 1;2016. doi: 10.1155/ 2016/2853040.

  65. Aghajanpour M, Nazer MR, Obeidavi Z, Akbari M, Ezati P, Kor NM. Functional foods and their role in cancer prevention and health promotion: A comprehensive review. Am J Cancer Res. 2017;7(4):740-69.

  66. Fechner A, Fenske K, Jahreis G. Effects of legume kernel fibres and citrus fibre on putative risk factors for colorectal cancer: A randomised, double-blind, crossover human intervention trial. Nutr J. 2013 Dec 1;12(1):101. doi: 10.1186/1475-2891-12-101.

  67. Pool-Zobel BL, Selvaraju V, Sauer J, Kautenburger T, Kiefer J, Richter KK, Soom M, Wolfl S. Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics. Carcinogenesis. 2005 Jun 1;26(6):1064-76.

  68. Arpaia N, Rudensky AY. Microbial metabolites control gut inflammatory responses. Proc Natl Acad Sci. 2014 Feb 11;111(6):2058-59.

  69. Sina C, Gavrilova O, Forster M, Till A, Derer S, Hildebrand F, Raabe B, Chalaris A, Scheller J, Rehmann A, Franke A. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J Immunol. 2009 Dec 1;183(11):7514-22.

  70. Steer TE, Gibson GR. The microbiology of phytic acid metabolism by gut bacteria and relevance for bowel cancer. Int J Food Sci Technol. 2002 Oct 1;37(7):783-90.

  71. Hou N, Huo D, Dignam JJ. Prevention of colorectal cancer and dietary management. Chin Clin Oncol. 2013 Jun;2(2):13. doi: 10.3978/j.issn.2304-3865.2013.04.03.

  72. Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E, Norat T. Dietary fibre, whole grains, and risk of colorectal cancer: Systematic review and dose-response meta-analysis of prospective studies. BMJ. 2011 Nov 10;343:d6617. doi: 10.1136/bmj.d6617.

  73. Oh H, Kim H, Lee DH, Lee A, Giovannucci EL, Kang SS, Keum N. Different dietary fibre sources and risks of colorectal cancer and adenoma: A dose-response meta-analysis of prospective studies. Brit J Nutr. 2019 Sep;122(6):605-15.

  74. Kim YI. Folate: A magic bullet or a double edged sword for colorectal cancer prevention? Gut. 2006 Oct 1;55(10):1387-89.

  75. Martinez ME, Henning SM, Alberts DS. Folate and colorectal neoplasia: Relation between plasma and dietary markers of folate and adenoma recurrence. Am J Clin Nutr. 2004 Apr 1;79(4):691-97.

  76. Lee JE, Willett WC, Fuchs CS, Smith-Warner SA, Wu K, Ma J, Giovannucci E. Folate intake and risk of colorectal cancer and adenoma: Modification by time. Am J Clin Nutr. 2011 Apr 1;93(4):817-25.

  77. Fujimori S, Gudis K, Takahashi Y, Kotoyori M, Tatsuguchi A, Ohaki Y, Sakamoto C. Determination of the minimal essential serum folate concentration for reduced risk of colorectal adenoma. Clin Nutr. 2011 Oct 1;30(5):653-8.

  78. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: A review. J Nutr. 2002 Aug 1;132(8):2350S-5S.

  79. Figueiredo JC, Mott LA, Giovannucci E, Wu K, Cole B, Grainge MJ, Logan RF, Baron JA. Folic acid and prevention of colorectal adenomas: A combined analysis of randomized clinical trials. Int J Cancer. 2011 Jul 1;129(1):192-203.

  80. Tanaka S, Haruma K, Yoshihara M, Kajiyama G, Kira K, Amagase H, Chayama K. Aged garlic extract has potential suppressive effect on colorectal adenomas in humans. J Nutr. 2006 Mar 1;136(3):821S-6S.

  81. Chiavarini M, Minelli L, Fabiani R. Garlic consumption and colorectal cancer risk in man: A systematic review and meta-analysis. Public Health Nutr. 2016 Feb;19(2):308-17.

  82. Morales-Oyarvide V, Meyerhardt JA, Ng K. Vitamin D and physical activity in patients with colorectal cancer: Epidemiological evidence and therapeutic implications. Cancer J (Sudbury, Mass.). 2016 May;22(3):223-31.

  83. Meggouh F, Lointier P, Saez S. Sex steroid and 1, 25-dihydroxyvitamin D3 receptors in human colorectal ade-nocarcinoma and normal mucosa. Cancer Res. 1991 Feb 15;51(4):1227-33.

  84. Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys. 2012 Jul 1;523(1):123-33.

  85. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980 Sep 1;9(3):227-31.

  86. Garland C, Garland F, Shaw E, Comstock G, Helsing K, Gorham E. Serum 25-hydroxyvitamin D and colon cancer: Eight-year prospective study. Lancet. 1989 Nov 18;334(8673):1176-8. doi: 10.1016/s0140-6736(89)91789-3.

  87. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW. Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. Am J Epidemiol. 1995 Sep 15;142(6):608.

  88. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Prevent Biomarker. 2004 Sep 1; 13(9): 1502-8.

  89. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006 Feb 16;354(7):684-96.

  90. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, Newmark HL, Giovannucci E, Wei M, Holick MF. Optimal vitamin D status for colorectal cancer prevention: A quantitative meta analysis. Am J Preventive Med. 2007 Mar 1;32(3):210-16.

  91. Chung MY, Lim TG, Lee KW. Molecular mechanisms of chemopreventive phytochemicals against gastroentero-logical cancer development. World J Gastroenterol. 2013 Feb 21;19(7):984-93.

  92. Patel VB, Misra S, Patel BB, Majumdar AP. Colorectal cancer: Chemopreventive role of curcumin and resveratrol. Nutr Cancer. 2010 Sep 23;62(7):958-67.

  93. Tennesen HH, Karlsen J. Studies on curcumin and curcuminoids. Zeitschrift Lebensmittel-Untersuchung Forschung. 1985 May 1;180(5):402-4.

  94. Sharma RA, Gescher A J, Steward WP. Curcumin: The story so far. Eur J Cancer. 2005 Sep 1;41(13):1955-68.

  95. Hsieh CY. Phase I clinical trial of curcumin, a chemopre-ventive agent, in patients with high-risk or premalignant lesions. Anticancer Res. 2001;21:2895-900.

  96. Garcea G, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ, Berry DP. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Brit J Cancer. 2004 Mar;90(5):1011-15.

  97. Garcea G, Berry DP, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ. Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Prevent Biomarker. 2005 Jan 1;14(1):120-25.

  98. Ramasamy TS, Ayob AZ, Myint HH, Thiagarajah S, Amini F. Targeting colorectal cancer stem cells using curcumin and curcumin analogues: Insights into the mechanism of the therapeutic efficacy. Cancer Cell Int. 2015 Dec 1;15(1):96. doi: 10.1186/s12935-015-0241-x.

  99. Lin L, Liu Y, Li H, Li PK, Fuchs J, Shibata H, Iwabuchi Y, Lin J. Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030. Brit J Cancer. 2011 Jul;105(2):212-20.

  100. Wang K, Zhang T, Liu L, Wang X, Wu P, Chen Z, Ni C, Zhang J, Hu F, Huang J. Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells. Int J Nanomed. 2012;7:4487-97.

  101. Park J, Conteas CN. Anti-carcinogenic properties of curcumin on colorectal cancer. World J Gastrointest Oncol. 2010 Apr 15;2(4):169-176.

  102. Frydoonfar HR, McGrath DR, Spigelman AD. Sulforaphane inhibits growth of a colon cancer cell line. Colorectal Dis. 2004 Jan;6(1):28-31.

  103. Gerhauser C. Epigenetic impact of dietary isothiocyanates in cancer chemoprevention. Curr Opin Clin Nutr Metabol Care. 2013 Jul 1;16(4):405-10.

  104. Yasuda S, Horinaka M, Sakai T. Sulforaphane enhances apoptosis induced by Lactobacillus pentosus strain SPT84 via the TNFa pathway in human colon cancer cells. Oncol Lett. 2019 Oct 1;18(4):4253-61.

  105. Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J, Terce F. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res. 2000 Mar 1;60(5):1426-33.

  106. Juge N, Mithen RF, Traka M. Molecular basis for chemoprevention by sulforaphane: A comprehensive review. Cell Mol Life Sci. 2007 May 1;64(9):1105-27.

  107. Kim MJ, Kim SH, Lim SJ. Comparison of the apoptosis-inducing capability of sulforaphane analogues in human colon cancer cells. Anticancer Res. 2010 Sep 1;30(9):3611-19.

  108. Kwon O, Soung NK, Thimmegowda NR, Jeong SJ, Jang JH, Moon DO, Chung JK, Lee KS, Kwon YT, Erikson RL, Ahn JS. Patulin induces colorectal cancer cells apoptosis through EGR-1 dependent ATF3 up-regulation. Cell Signal. 2012 Apr 1;24(4):943-50.

  109. Jin H, Gong W, Zhang C, Wang S. Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling. OncoTarget Ther. 2013;6:145-53.

  110. Jin H, Tan X, Liu X, Ding Y. The study of effect of tea polyphenols on microsatellite instability colorectal cancer and its molecular mechanism. Int J Cancer Colorectal Dis. 2010 Dec 1;25(12):1407-15.

  111. Md Nesran ZN, Shafie NH, Ishak AH, Mohd Esa N, Ismail A, Md Tohid SF. Induction of endoplasmic reticulum stress pathway by green tea epigallocatechin-3-gallate (EGCG) in colorectal cancer cells: Activation of PERK/ p-eIF2a/ATF4 and IRE1a. Biomed Res Int. 2019 Dec 1;2019. doi: 10.1155/2019/3480569.

  112. Rotelli MT, Bocale D, De Fazio M, Ancona P, Scalera I, Memeo R, Travaglio E, Zbar AP, Altomare DF. In vitro evidence for the protective properties of the main components ofthe Mediterranean diet against colorectal cancer: A systematic review. Surg Oncol. 2015 Sep 1;24(3):145-52.

  113. Honari M, Shafabakhsh R, Reiter RJ, Mirzaei H, Asemi Z. Resveratrol is a promising agent for colorectal cancer prevention and treatment: Focus on molecular mechanisms. Cancer Cell Int. 2019 Dec;19(1):180. doi: 10.1186/ s12935-019-0906-y.

  114. Trung LQ, An DT. Is resveratrol a cancer immunomod-ulatory molecule? Front Pharmacol. 2018 Nov 6;9:1255. doi: 10.3389/fphar.2018.01255.

  115. Kaminski BM, Weigert A, Scherzberg MC, Ley S, Gilbert B, Brecht K, Brune B, Steinhilber D, Stein J, Ulrich-Ruckert S. Resveratrol-induced potentiation of the antitumor effects of oxaliplatin is accompanied by an altered cytokine profile of human monocyte-derived macrophages. Apoptosis. 2014 Jul 1;19(7):1136-47.

  116. Buhrmann C, Yazdi M, Popper B, Shayan P, Goel A, Aggarwal BB, Shakibaei M. Resveratrol chemosensitizes TNF-P-induced survival of 5-FU-treated colorectal cancer cells. Nutrients. 2018 Jul;10(7):888. doi: 10.3390/ nu10070888.

  117. Wang Y, Yu H, Zhang J, Gao J, Ge X, Lou G. Hesperidin inhibits HeLa cell proliferation through apoptosis mediated by endoplasmic reticulum stress pathways and cell cycle arrest. BMC Cancer. 2015 Dec 1;15(1):682. doi: 10.1186/s12885-015-1706-y.

  118. Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, Satoh K, Hara A, Sumida T, Tanaka T, Ogawa H. Chemo-prevention of azoxymethane-induced rat colon carcino-genesis by the naturally occurring flavonoids diosmin and hesperidin. Carcinogenesis. 1997 May 1;18(5):957-65.

  119. Ismail IA, Gabry MS, Abdalla SK, Ibrahim MA. P53 sensitizes human colon cancer cells to hesperidin through up-regulation of Bax and P21. Egypt J Biochem Mol Biol. 2012 Dec 1;30(2):185-202.

  120. Chung WG, Miranda CL, Stevens JF, Maier CS. Hop pro-anthocyanidins induce apoptosis, protein carbonylation, and cytoskeleton disorganization in human colorectal adenocarcinoma cells via reactive oxygen species. Food Chem Toxicol. 2009 Apr 1;47(4):827-36.

  121. Zu XY, Zhang ZY, Zhang XW, Yoshioka M, Yang YN, Ji LI. Anthocyanins extracted from Chinese blueberry (Vaccinium uliginosum L.) and its anticancer effects on DLD-1 and COLO205 cells. Chin Med J. 2010 Oct 1;123(19):2714-19.

  122. Fridrich D, Teller N, Esselen M, Pahlke G, Marko D. Comparison of delphinidin, quercetin and (-)-epigallocatechin-3-gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation. Mol Nutr Food Res. 2008 Jul;52(7):815-22.

  123. Quintos L, Lee I, Kim HJ, Lim JS, Park J, Sung MK, Seo YR, Kim JS. Significance of p27kip1 as potential bio-marker for intracellular oxidative status. Nutr Res Pract. 2010 Oct 1;4(5):351-55.

  124. Larsson SC, Bergkvist L, Rutegard J, Giovannucci E, Wolk A. Calcium and dairy food intakes are inversely associated with colorectal cancer risk in the cohort of Swedish men. Am J Clin Nutr. 2006 Mar 1;83(3): 667-73.

  125. Park Y, Leitzmann MF, Subar AF, Hollenbeck A, Schatzkin A. Dairy food, calcium, and risk of cancer in the NIH-AARP diet and health study. Arch Intern Med. 2009 Feb 23;169(4):391-401.

  126. Moorman PG, Terry PD. Consumption of dairy products and the risk of breast cancer: A review of the literature. Am J Clin Nutr. 2004 Jul 1;80(1):5-14.

  127. Kumari S, Yong Meng G, Ebrahimi M. Conjugated linoleic acid as functional food in poultry products: A review. Int J Food Properties. 2017 Mar 4;20(3):491-506.

  128. Lamprecht SA, Lipkin M. Chemoprevention of colon cancer by calcium, vitamin D and folate: Molecular mechanisms. Nat Rev Cancer. 2003 Aug;3(8):601-14.

  129. Castro-Webb N, Ruiz-Narvaez EA, Campos H. Cross-sectional study of conjugated linoleic acid in adipose tissue and risk of diabetes. Am J Clin Nutr. 2012 Jul 1;96(1):175-81.

  130. Bartke A. Minireview: Role of the growth hormone/insulin-like growth factor system in mammalian aging. Endocrinology. 2005 Sep 1;146(9):3718-23.

  131. Gupta MK, Vadde R. In silico identification of natural product inhibitors for y-secretase activating protein, a therapeutic target for Alzheimer's disease. J Cell Biochem. 2019 Jun;120(6):10323-36.

  132. Gupta MK, Vadde R. Insights into the structure-function relationship of both wild and mutant zinc transporter ZnT8 in human: A computational structural biology approach. J Biomol Struct Dyn. 2019 Jan; 38(1):137-51.

  133. Falzone L, Scola L, Zanghi A, Biondi A, Di Cataldo A, Libra M, Candido S. Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development. Aging (Albany NY). 2018 May;10(5):1000-14.

  134. Yang W, Ma J, Zhou W, Li Z, Zhou X, Cao B, Zhang Y, Liu J, Yang Z, Zhang H, Zhao Q. Identification of hub genes and outcome in colon cancer based on bioinformatics analysis. Cancer Manage Res. 2019;11:323-38.

  135. Ramakrishna V, Janardhan PB, Sudarsanareddy L. Stem cells and regenerative medicine-a review. Annu Res Rev Biol. 2011 Jul 15:79-110. 136. Gupta MK, Vemula S, Donde R, Gouda G, Behera L, Vadde R. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. J Biomol Struct Dyn. 2020 Apr 13:1-11. doi: 10.1080/07391102.2020.17513 00.

CITED BY
  1. Yuan Meng, Zhang Guoqing, Bai Weijun, Han Xin, Li Chan, Bian Siman, Qin Si, The Role of Bioactive Compounds in Natural Products Extracted from Plants in Cancer Treatment and Their Mechanisms Related to Anticancer Effects, Oxidative Medicine and Cellular Longevity, 2022, 2022. Crossref

  2. Sarojamma Vemula , Vadde Ramakrishna, Naringenin in the Prevention of Colon Cancer: An Updated Review , Onco Therapeutics, 9, 2, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain